JP Patent

JP6882205B2 — 重度腎機能障害を有する癌患者に対する治療方法

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2021-06-02 · 5y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP6882205B2
Jurisdiction: JP
Classification: —
Expires: 2021-06-02
Drug substance claim: No
Drug product claim: No
Assignee: Taiho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.